logo-loader

Updates

Health

Genedrive PLC - Interim Results for the six months to December 2017

Genedrive's PLC (LON: GDR) HepC test just entered the commercial phase as partner Sysmex...

on 21/3/18
Energy

Rose Petroleum - Update on 3D seismic data interpretation

Rose Petroleum (LON:ROSE) announced the completion of the initial structural interpretation...

on 7/2/18
Finance

PCF Group - Forecast Update

Following the release of the 2017 full year results for the financial year to end September...

on 29/1/18
Retail & consumer

McColl's - Positioned to Succeed

McColl’s (LON:MCLS) is one of the UK’s leading neighbourhood retailers, with a growing estate...

on 8/1/18

Analyst interviews

Revive Therapeutics: Analyst sees 'substantial upside potential' as key...

Proactive Research analyst Ed Stacey says Revive Therapeutics (CSE:RVV)(OTCQB:RVVTF) is a speciality life sciences company focussed on repurposing drugs for rare and infectious diseases and has a pipeline of of three main platforms. One of them is Bucillamine (BUC) which is a medication with a...

2 days ago